Navigation Links
Titan Pharmaceuticals Announces Journal of the American Medical Association Publication of Phase 3 Probuphine™ Data
Date:10/12/2010

SOUTH SAN FRANCISCO, Calif., Oct. 12 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (OTC Bulletin Board: TTNP) today announced that data from its previously completed and announced Phase 3 randomized, placebo-controlled clinical trial of Probuphine were published in the Journal of the American Medical Association (JAMA).  The article highlights data from the 163-patient trial, which showed that patients receiving Titan's Probuphine implant had significantly less illicit opioid use, experienced fewer symptoms of withdrawal and craving, stayed in treatment longer and had greater overall improvement when compared to placebo patients over the course of the 24-week study.

Probuphine is an innovative, subcutaneous implant formulation designed using Titan's proprietary ProNeura™ technology to deliver a steady, round-the-clock low dose of the marketed drug buprenorphine over six months following a single treatment.

"The introduction of buprenorphine into clinical practice is arguably the most significant improvement in the treatment of opioid addiction in the last decade; however, physicians excited with the clinical success of buprenorphine are also rightfully concerned about medication adherence and diversion - and potential for abuse - of the sublingual formulations of buprenorphine," said Walter Ling, M.D., Professor of Psychiatry and Director, Integrated Substance Abuse Programs at the David Geffen School of Medicine at UCLA and the paper's lead author.  "Probuphine does away with these concerns by eliminating the need for take home doses. Additionally, by providing a sustained blood level of active medication, Probuphine helps diminish the daily fluctuation of the medication effects—and potentially side effects-- and reduces the total exposure of buprenorphine over time."  

The publication, "Buprenorphine Implants for Opioid Depende
'/>"/>

SOURCE Titan Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Ascension Orthopedics Announces First Implantations of TITAN™ Modular Shoulder
2. Ascension Orthopedics Receives FDA Approval for TITAN™ Modular Total Shoulder System
3. Cardiac Dimensions® Announces Presentation of 12-Month Follow-up Data of TITAN™ Trial at European Society of Cardiology Meeting
4. Titan Pharmaceuticals Announces Second Quarter 2010 Financial Results
5. Cempra Pharmaceuticals Names Richard Kent, M.D., to Its Board of Directors
6. Reportlinker Adds Sales Force Effectiveness in Pharmaceuticals - Cost Pressures Increase Pharmaceutical Companies Adoption of New Sales Models and Technologies
7. Auxilium Pharmaceuticals, Inc. Announces Issuance of Patent for Clostridial Collagenase
8. Jazz Pharmaceuticals Receives FDA Complete Response Letter Regarding JZP-6 for Treatment of Fibromyalgia
9. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
10. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
11. Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... BOTHELL, Wash. and VANCOUVER, British Columbia ... OGXI ), a leader in the development of ... today announced that four trials of its investigational compounds, custirsen ... at the 49 th Annual Meeting of the American ... from May 31 – June 4. ...
(Date:5/21/2013)... Mass. , May 21, 2013  NxStage Medical, ... of innovative dialysis products, today announced that it has ... critical care and in-center products to DaVita, the kidney ... http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ) For the use ... United States , NxStage has executed a second ...
(Date:5/21/2013)... 21, 2013   Regulus Therapeutics Inc . ( ... and development of innovative medicines targeting microRNAs, today announced ... Chief Operating Officer and Executive Vice President, Finance, will ... Annual Healthcare Conference on Wednesday, May 29, 2013 at ... the Westin Boston Waterfront Hotel. The presentation ...
Breaking Medicine Technology:OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 2OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 3OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 4OncoGenex Announces Multiple 'Trials in Progress' Presentations at the 2013 ASCO Annual Meeting 5NxStage Announces New Agreements with DaVita 2Regulus to Present at Deutsche Bank 38th Annual Healthcare Conference 2
... Concord Medical Services Holdings Limited ("Concord Medical" or ... operator of the largest network of radiotherapy and ... it has signed an Memorandum of Understating ("MOU") ... Electric International Operations Company, Inc. and GE Medical ...
... 2011 China Nuvo Solar Energy, Inc. (OTCQB: CNUV) ... with Tandem Receivable Solutions to a western distributorship. Tandem, ... committed to assisting the Company from sales through collections ... Tom Toland, CEO of SurgLine stated, "As business ...
Cached Medicine Technology:Concord Medical and GE Healthcare Sign MOU for Preferred Partnership in China 2China Nuvo Solar Target Acquisition SurgLine Announces Agreement With Western U.S. Distributor 2China Nuvo Solar Target Acquisition SurgLine Announces Agreement With Western U.S. Distributor 3
(Date:5/22/2013)... (PRWEB) May 22, 2013 Athletic-Minded ... and publishing company released today its 2013 U.S. ... business hotels received the company’s recommendation after ongoing ... anonymous personal tours by the editorial staff. ... lap pool, sport court, etc.), in-room workout choices, ...
(Date:5/21/2013)... 22, 2013 The University of Colorado’s ... with HEALTHY DINING to help Coloradans make healthier choices ... new program is called HEALTHY DINING IN COLORADO. ... already participating in Colorado. Restaurants will offer a selection ... emphasizing lean protein, vegetables, fruits, whole grains and unsaturated ...
(Date:5/21/2013)... (PRWEB) May 22, 2013 Swimsuit season is ... Cellulite Whisperer ® products has begun with a 35% discount. ... to estrogen. Many women get the dreaded cellulite even if ... beneath the skin where they have been stored as toxic ... are no easy fixes, a specific program that works to ...
(Date:5/21/2013)... Feed additives have now become an ... chain. Most of the feed additives are used in ... and powders. There are variety of feed additives available ... upon the type of animal and feed. Nutritional feed ... essential nutrition to the animal in order to gain ...
(Date:5/21/2013)... WASHINGTON (May 22, 2013)Today the George Washington ... Health Services (SPHHS) announced the launch of ... Immigrant/Refugee Health, a collaboration between SPHHS, the ... and other community partners. This university-community partnership ... disproportionately affect Latino communities through research, mutual ...
Breaking Medicine News(10 mins):Health News:2013: The 10 Healthiest Business Hotels in the U.S. 2Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 2Health News:Colorado Takes a Huge Step toward Transforming the Family Dining Experience 3Health News:Diminish Cellulite for Swimsuit Season; Sublime Beauty Introduces Cellulite Whisperer® Products in the "Get Ready for Summer Sale" 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 2Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 3Health News:Protease Leads Feed Enzyme Market as Compared to Phytase & NSP Says New Research Report at ReportsnReports.com 4Health News:GW launches center to address health disparities in the Latino immigrant community 2Health News:GW launches center to address health disparities in the Latino immigrant community 3
... brain activity in children's with autism and found ... children. The Researchers found //that the autism children's had ... observation and imitating others action and expressing facial response. ... Nature Neuroscience. ,Autism is a developmental disorder ...
... habits and increased weight in the middle school students reports ... employment of food as motivation resulted in an increase in ... food and organizing fund raising programs with food as a ... About two thirds of adults and on third of children ...
... on behalf of the HIV positive people of Mizo society to ... Malsawmdawnga who is the president of Mizoram People Living With AIDS// ... world is changing for the better and awareness about AIDS is ... up. ,He condemned the practice of sealing the ...
... the press about improvising the health care facilities at Patna ... more hospitals with ICUs// and ambulance facilities 24-hour health care ... , ,He put forth the idea about giving certain ... He also mentioned that the chief minister Mr. Nitish Kumar ...
... in India has called for curtailing comparative advertisements, after ... should be made to the Code for Commercial Advertising ... and the Monopolies and Restrictive Trade Practices Act in ... in some western nations where advertisements attacking the products ...
... Bhopal: The 21st anniversary of the Bhopal gas leak tragedy ... and Research Center resigned. , ,The doctors wanted a ... visit for treatment daily. Run by a trust, the BMHRC ... Apart from the survivors of the gas victims, it also ...
Cached Medicine News:Health News:Conditions Of The HIV/AIDS Patients In The Mizo Society 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: